Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-30,000
Closed -$2.27M 4535
2023
Q1
$2.27M Buy
+30,000
New +$2.3M ﹤0.01% 2605
2022
Q1
Sell
-56,400
Closed -$3.73M 5914
2021
Q4
$3.73M Hold
56,400
﹤0.01% 2717
2021
Q3
$3.57M Buy
+56,400
New +$3.72M ﹤0.01% 2456
2015
Q1
Sell
-40,000
Closed -$2.23M 3985
2014
Q4
$2.23M Hold
40,000
﹤0.01% 2189
2014
Q3
$2.11M Hold
40,000
﹤0.01% 2199
2014
Q2
$2.09M Sell
40,000
-24,800
-38% -$1.23M ﹤0.01% 2267
2014
Q1
$3.13M Sell
64,800
-131,000
-67% -$6.09M ﹤0.01% 1954
2013
Q4
$8.79M Sell
195,800
-107,200
-35% -$4.76M 0.01% 1243
2013
Q3
$13M Sell
303,000
-29,000
-9% -$1.23M 0.02% 841
2013
Q2
$13.6M Buy
+332,000
New +$13.5M 0.03% 711

Other funds holding SRE

David Shaw's SRE Position: Q2 2026 in Review

David Shaw sold out of Sempra (SRE) in Q2 2026, closing a stake of 672,770 shares — an estimated $65.4M sold.

David Shaw first reported a position in SRE in Q2 2013 and held it in 46 quarters. The position peaked at $142M in Q1 2020. 1,280 funds tracked by Wall St. Rank hold SRE as of Q2 2026.

  • David Shaw reported no remaining Sempra position as of Q2 2026 after selling out during the quarter.
  • David Shaw sold 672,770 Sempra shares in Q2 2026, an estimated $65.4M.
  • David Shaw first reported a position in Sempra in Q2 2013 and held it in 46 quarters.
  • David Shaw's Sempra position peaked at $142M in Q1 2020.
  • 1,280 funds tracked by Wall St. Rank held Sempra as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.